BDBM50121922 7-(9-Hydroxy-2-isobutyl-2-methyl-3-oxo-2,3,9,9a-tetrahydro-1H-imidazo[1,2-a]indol-9-ylmethyl)-6,7-dihydro-6,8,13a-triaza-benzo[3,4]cyclohepta[1,2-b]naphthalene-5,13-dione::CHEMBL357749

SMILES CC(C)C[C@]1(C)N[C@H]2N(C1=O)c1ccccc1[C@@]2(O)C[C@@H]1NC(=O)c2ccccc2-n2c1nc1ccccc1c2=O

InChI Key InChIKey=LBTHQRPRHJDQRG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50121922   

TargetGastrin/cholecystokinin type B receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50121922(7-(9-Hydroxy-2-isobutyl-2-methyl-3-oxo-2,3,9,9a-te...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of Cholecystokinin type B receptor induced guinea pig gall bladder contractions when given intravenouslyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2012
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50121922(7-(9-Hydroxy-2-isobutyl-2-methyl-3-oxo-2,3,9,9a-te...)
Affinity DataIC50: 1.40E+3nMAssay Description:Concentration required for 50% inhibition of Cholecystokinin type A receptor in rat pancreatic tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2012
Entry Details Article
PubMed